Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance | Zendy

Rosa de Miguel Buckley | Zendy; David RialCrestelo | Zendy; Rocío Montejano | Zendy; Adriana Pinto | Zendy; María Jiménez-González | Zendy; María Lagarde | Zendy; Andrés Esteban-Cantos | Zendy; Paula Aranguren-Rivas | Zendy; Julen Cadiñanos | Zendy; Otilia Bisbal | Zendy; Juan Castro | Zendy; Mireia Santacreu-Guerrero | Zendy; Laura Bermejo-Plaza | Zendy; V. Moreno | Zendy; Asunción Hernando | Zendy; Luz MartínCarbonero | Zendy; Rafael Rubio | Zendy; Rafaël Delgado | Zendy; José Ramón Arribas | Zendy; Federico Pulido | Zendy

Open Access

Long-term Evaluation of Residual Viremia in a Clinical Trial of Dolutegravir Plus Lamivudine as Maintenance Treatment for Participants With and Without Prior Lamivudine Resistance

Author(s) -

Rosa de Miguel Buckley,

David RialCrestelo,

Rocío Montejano,

Adriana Pinto,

María Jiménez-González,

María Lagarde,

Andrés Esteban-Cantos,

Paula Aranguren-Rivas,

Julen Cadiñanos,

Otilia Bisbal,

Juan Castro,

Mireia Santacreu-Guerrero,

Laura Bermejo-Plaza,

V. Moreno,

Asunción Hernando,

Luz MartínCarbonero,

Rafael Rubio,

Rafaël Delgado,

José Ramón Arribas,

Federico Pulido

Publication year - 2022

Publication title -

open forum infectious diseases

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.546

H-Index - 35

ISSN - 2328-8957

DOI - 10.1093/ofid/ofac610

Subject(s) - lamivudine , dolutegravir , viremia , medicine , virology , clinical trial , population , resistance mutation , viral load , virus , genetics , hepatitis b virus , biology , polymerase chain reaction , reverse transcriptase , antiretroviral therapy , environmental health , gene

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research